Clinical Trials · NCT00796289
Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 350
- Start date
- Feb 2009
- Locations
- 35 sites, United States
- Primary endpoint
- Ovulation rate